Latest Breaking News On - Fabrice viviani - Page 1 : comparemela.com

Oncodesign Services, a Leading European CRO In Preclinical Drug Discovery Acquires ZoBio, A CRO Specialized in Small Molecule Drug Discovery

Oncodesign Services, a Leading European CRO In Preclinical Drug Discovery Acquires ZoBio, A CRO Specialized in Small Molecule Drug Discovery
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesStefan klotterGregg siegalStephanie belattarLes ulisFabrice vivianiGilles cadiouSebastien simonRob heetebrijJan schultzPrnewswire oncodesign servicesContract research organizationOncodesign servicesDrug discoveryMaxence de vienneElyan partners

ERES IV acquires a majority stake in Oncodesign Services

Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners announce the completion of the acquisition of a majority stake in Oncodesign Services by ERES IV, representing 61.58% of its share capital, from its main shareholders, including Mr. Philippe Genne, Founder of Oncodesign Services, as well as certain key shareholders and several managers and minority shareholders, following the entry into exclusive negotiations on June 30, 2022.

Karine lignelPhilippe genneLaure lamm coutardMaria osipovaFabrice vivianiOncodesign servicesfebCatherine genneKamel besseghirJan hoflackContract research organizationDistribution to oncodesign servicesServices oncodesignDrug discovery servicesOncodesign servicesOncodesign groupFounder of oncodesign services

Oncodesign Services looks to the future

As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future.

United statesUnited kingdomFabrice vivianiMaria osipovaOncodesign servicesfebDrug discovery servicesOncodesign servicesAlira healthFrom oncodesign servicesfebImage creditOncodesign precision medicinePrecision medicineEdmond de rothschild equity strategiesIntegrated drug discoveryElyan partnersNorth america

EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company s Remaining Shares

EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company s Remaining Shares
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesKarine lignelPhilippe genneLaure lamm coutardArthur rouillBredin pratFabrice vivianiMathilde bohinCatherine genneArthaud associesKamel besseghirJan hoflackContract research organizationServices oncodesignOncodesign services paris

ONCODESIGN Announces the Separation of Its Two Business Lines - Service and Biotech - and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer

The planned transactions are as follows: The subsidiarisation by ONCODESIGN of its Biotech/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary

France generalUnited statesArthur rouillFabrice vivianiMathilde bohinOlivier arthaudPhilippe genneUniversity hospitalGarnier coBus serviceEdmond de rothschild groupDrug discovery serviceDrug discoveryArtificial intelligenceEdmond de rothschild equity strategiesElyan partners